Global Psoriatic Arthritis Therapeutics Market 2019-2023

A few of the key findings from our psoriatic arthritis therapeutics market forecast report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.

Get a FREE sample now!

Global Psoriatic Arthritis Therapeutics Industry Overview

Difficulty in identifying the pathogenesis of psoriatic arthritis has resulted in the lack of curative therapies for the indication. This has driven market vendors and research organizations to focus on the development of regenerative therapies such as stem cell therapy for curing psoriatic arthritis. One such development is the administration of umbilical cord Wharton’s Jelly stem cells (WJSCs) in psoriatic arthritis patients. Studies conducted by Invitrx Inc. have also shown that the human umbilical cord stem cell therapy can provide complete remission of symptoms such as joint pain and psoriatic plaques and normalize inflammatory markers C-reactive protein and erythrocyte sedimentation rate. These methods of treatment have proven to be highly effective in curing psoriatic arthritis. Although these regenerative therapies are in the early stages of development, further advances in research will boost their demand for the identification of pathogenesis and cause of psoriatic arthritis. Thus, the advent of regenerative therapy has been identified as one of the critical psoriatic arthritis therapeutics market trends. The trend will have a positive influence on the growth of the market over the forecast period.

The expiry of patents of most of the drugs in the global PsA therapeutics market has resulted in the development of biosimilars of significant therapeutics. Although biosimilars are reasonably priced, their cost is still higher than small molecule drugs. The high efficacy of biologics in the treatment of psoriatic arthritis therapeutics is also responsible for their increased sales. These factors are restricting the growth of small molecule drugs. Moreover, the patent expansion of the key blockbuster drug, HUMIRA, will help in partially offsetting the value erosion caused by the entry of biosimilars. As a result, the dominance of biologics will grow and drive the psoriatic arthritis therapeutics market growth at a CAGR of almost 9% during the forecast period.

Top Psoriatic Arthritis Therapeutics Companies Covered in the Market Research Report

The global psoriatic arthritis therapeutics market is concentrated. To help clients in improving their market positions, the report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, the market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.

The report offers a detailed analysis of several leading psoriatic arthritis therapeutics companies, including:

• AbbVie Inc.
• Celgene Corp.
• Johnson & Johnson Services Inc.
• Novartis AG
• Pfizer Inc.

Psoriatic Arthritis Therapeutics Market Segmentation Based on Type

• Biologics
• Small molecules

The biologics segment will account for the highest psoriatic arthritis therapeutics market share. The strong efficacy of approved drugs, availability of patient assistance programs, strong patient pool, and increasing awareness campaigns are a few of the factors fueling the growth of the segment. The report provides an accurate prediction of the contribution of all the segments to the growth of the psoriatic arthritis therapeutics market size.

Psoriatic Arthritis Therapeutics Market Segmentation Based on Geographic Region

• Asia
• Europe
• North America
• ROW

With a complete study of the growth opportunities for the companies, it has been identified that North America will account for the highest share of the PsA therapeutics market throughout the forecast period. Factors such as strong dominance of biologics, availability of various patient assistance programs, and the presence of advanced healthcare infrastructure are contributing to the growth of the market in the region.

Key Highlights of the Global Psoriatic Arthritis Therapeutics Market for the Forecast Years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the psoriatic arthritis therapeutics market during the next five years
• Precise estimation of the global psoriatic arthritis therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of the companies

We can help! Our analysts can customize the market research report to meet your requirements. Get in touch